Physician profile
Stephen Oh
NPI 1881867695
$2,879.56
in general payments reported to CMS, 2019-2025
22 companies · $460 in 2025
The $460 reported for 2025 was more than what 86% of Anatomic Pathology & Clinical Pathology providers received nationally (typical 2025 total: $50.59).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57.95 · 2020: $449 · 2021: $350 · 2022: $825 · 2023: $418 · 2024: $321 · 2025: $460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,198.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $709.33 | 2020-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $585.81 | 2020-2022 | |
| Janssen Biotech, INC. | $351.61 | 2022-2024 | Stelara, Tremfya |
| Boston Scientific Corporation | $265.14 | 2025 | Overstitch Endoscopic Suturing System, Axonics |
| Lilly USA, LLC | $125.06 | 2022 | |
| Amgen INC. | $125.00 | 2025 | Tepezza |
| Novo Nordisk INC | $115.87 | 2023 | Wegovy |
| Qol Medical, LLC | $93.94 | 2020-2022 | |
| Alfasigma USA, INC. | $71.13 | 2020 | |
| Intuitive Surgical, INC. | $66.93 | 2020 | |
| Quidel Corporation | $63.08 | 2023 | |
| Evoke Pharma, INC. | $48.81 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $43.09 | 2021 | |
| Myriad Women'S Health, INC. | $42.99 | 2023 | Myrisk |
| Axonics, INC. | $31.78 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $24.06 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $23.62 | 2023 | Dupixent |
| Vivus LLC | $20.78 | 2025 | Qsymia |
| Shionogi INC | $20.19 | 2019 | |
| Biofire Diagnostics, LLC | $20.01 | 2020 | |
| Intercept Pharmaceuticals, INC. | $17.63 | 2023 | Ocaliva |
| Daiichi Sankyo INC. | $13.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Oh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.